SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-165785
Filing Date
2022-06-02
Accepted
2022-06-02 08:00:33
Documents
12
Period of Report
2022-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d319873d8k.htm   iXBRL 8-K 30739
  Complete submission text file 0001193125-22-165785.txt   156508

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA caba-20220601.xsd EX-101.SCH 2871
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20220601_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20220601_pre.xml EX-101.PRE 11717
6 EXTRACTED XBRL INSTANCE DOCUMENT d319873d8k_htm.xml XML 3468
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 22989284
SIC: 2836 Biological Products, (No Diagnostic Substances)